Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_assertion type Assertion NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_head.
- NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_assertion wasGeneratedBy ECO_0000203 NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_provenance.
- NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_assertion wasDerivedFrom befree-20140225 NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_provenance.
- NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_assertion SIO_000772 18826852 NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_provenance.
- NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_assertion evidence source_evidence_literature NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_provenance.
- NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_assertion description "[Selective VDR ligands, in particular, may offer additional benefits in the treatment of bone disease, and may potentially reduce adverse effects related to cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628340.RAX1e80ouAOxo25OGN4aRuZXkL436v1INCquyUta4dZaI130_provenance.